Europe Digital Polymerase Chain Reaction Market Forecast 2017-2025
KEY FINDINGS The Europe digital PCR market was valued $71 million in the year 2016. The market is expected to grow at a CAGR of 31.42% over the forecast period of 2017-2025 and generate $901 million by the end of 2025. MARKET INSIGHTS The European market is mainly divided into three segments: the products and services, the end-users, and the applications. The products and service segment is sub-segmented into software solutions, reagents and consumables, and instruments. Of these, the instruments segment is the most popular. The end-users comprise of forensic laboratories, clinical research laboratories, biotech and pharma companies, etc. and the market finds its application in clinical studies, research, and forensics. In spite of such a wide scope, the market is under a threat from challenges such as the implementation of MIQE guidelines for publishing any dPCR-based research and the increasing availability of alternative technologies. COMPETITIVE INSIGHTS Some of the prominent companies in the market are: F. Hoffman-La Roche Ltd, Bio-Rad Laboratories, Inc, Fluidigm Corporation, Qiagen N.V, Gennova Scientific Sl, Thermo Fisher Scientific Inc, Raindance Technologies, Inc. (Acquired by Bio-Rad Laboratories, Inc), etc.